Suchergebnisse - "Mussini, C"

PubPharm (24)

1

Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens : A Prospective RESPOND Cohort Study

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Álvarez, H. | Mocroft, A. | Ryom, L. | +130

2

Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral-naïve persons starting treatment

enthalten in: HIV medicine | 2020

von Mocroft, A. | Neesgard, B. | Zangerle, R. | +29

3

Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort

enthalten in: HIV medicine | 2020

von Taramasso, L. | Fabbiani, M. | Nozza, S. | +31

4

Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection

enthalten in: The New England journal of medicine | 2020

von Kozal, M. | Aberg, J. | Pialoux, G. | +116

5

Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?

enthalten in: HIV medicine | 2018

von Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord | Monge, S. | Mocroft, A. | +98

6

Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL

enthalten in: Infection | 2017

von Madeddu, G. | Rusconi, S. | Cozzi-Lepri, A. | +108

7

Atazanavir/ritonavir monotherapy : 96 week efficacy, safety and bone mineral density from the MODAt randomized trial

enthalten in: The Journal of antimicrobial chemotherapy | 2016

von Galli, L. | Spagnuolo, V. | Bigoloni, A. | +55

8

HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels

enthalten in: The Journal of antimicrobial chemotherapy | 2016

von Di Maio, V. | Cento, V. | Di Paolo, D. | +147

9

Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study

enthalten in: HIV medicine | 2015

von Podlekareva, D. | Grint, D. | Karpov, I. | +110

10

Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus

enthalten in: PloS one | 2015

von Mussini, C. | Lorenzini, P. | Puoti, M. | +109